TP53 variants underlying pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remission

EJHaem Pub Date : 2024-08-20 DOI:10.1002/jha2.986
Albert Itov, Karina Ilyasova, Olga Soldatkina, Anna Kazakova, Vladimir Kozeev, Alexandra Semchenkova, Elena Osipova, Elmira Boichenko, Egor Volchkov, Alexander Popov, Elena Zerkalenkova, Julia Roumiantseva, Galina Novichkova, Alexander Karachunskiy, Yulia Olshanskaya
{"title":"TP53 variants underlying pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remission","authors":"Albert Itov,&nbsp;Karina Ilyasova,&nbsp;Olga Soldatkina,&nbsp;Anna Kazakova,&nbsp;Vladimir Kozeev,&nbsp;Alexandra Semchenkova,&nbsp;Elena Osipova,&nbsp;Elmira Boichenko,&nbsp;Egor Volchkov,&nbsp;Alexander Popov,&nbsp;Elena Zerkalenkova,&nbsp;Julia Roumiantseva,&nbsp;Galina Novichkova,&nbsp;Alexander Karachunskiy,&nbsp;Yulia Olshanskaya","doi":"10.1002/jha2.986","DOIUrl":null,"url":null,"abstract":"<p>Pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia (LH-ALL) with <i>TP53</i> variants has been proposed to be considered a manifestation of Li-Fraumeni syndrome (LFS). However, our study demonstrates that of the majority the pathogenic variants in the TP53 gene are somatic (70.5%), and only 12.5% of patients with germline fulfilled the criteria of LFS. We also describe the first case of hypodiploid BCP-ALL with a mosaic pathogenic mutation in <i>TP53</i> and the first case of the persistence of clonal hematopoiesis with the <i>TР53</i> gene mutation in the child during 3-year minimal residual disease-negative remission, similar to what has been described in adults.</p>","PeriodicalId":72883,"journal":{"name":"EJHaem","volume":"5 5","pages":"1010-1013"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jha2.986","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJHaem","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jha2.986","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pediatric low-hypodiploidy B-cell acute lymphoblastic leukemia (LH-ALL) with TP53 variants has been proposed to be considered a manifestation of Li-Fraumeni syndrome (LFS). However, our study demonstrates that of the majority the pathogenic variants in the TP53 gene are somatic (70.5%), and only 12.5% of patients with germline fulfilled the criteria of LFS. We also describe the first case of hypodiploid BCP-ALL with a mosaic pathogenic mutation in TP53 and the first case of the persistence of clonal hematopoiesis with the TР53 gene mutation in the child during 3-year minimal residual disease-negative remission, similar to what has been described in adults.

Abstract Image

小儿低倍半整倍体 B 细胞急性淋巴细胞白血病的 TP53 变异显示出不同的起源,并可能在缓解期作为造血克隆持续存在
有人认为,带有TP53变体的小儿低倍性B细胞急性淋巴细胞白血病(LH-ALL)是李-弗劳米尼综合征(LFS)的一种表现形式。然而,我们的研究表明,大多数 TP53 基因的致病变异都是体细胞变异(70.5%),只有 12.5% 的种系变异患者符合 LFS 的标准。我们还描述了首例TP53基因致病突变的低二倍体BCP-ALL病例,以及首例TР53基因突变的克隆性造血在患儿3年最小残留病阴性缓解期间持续存在的病例,这与成人的情况类似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信